Repligen Corp (RGEN)
165.66
-2.20
(-1.31%)
USD |
NASDAQ |
Apr 25, 16:00
165.54
-0.12
(-0.07%)
After-Hours: 20:00
Repligen Free Cash Flow: 74.93M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
December 31, 2023 | 74.93M |
September 30, 2023 | 97.48M |
June 30, 2023 | 51.15M |
March 31, 2023 | 45.58M |
December 31, 2022 | 38.74M |
September 30, 2022 | 14.50M |
June 30, 2022 | 41.48M |
March 31, 2022 | 42.43M |
December 31, 2021 | 47.74M |
September 30, 2021 | 34.66M |
June 30, 2021 | 40.18M |
March 31, 2021 | 31.98M |
December 31, 2020 | 36.28M |
September 30, 2020 | 43.66M |
June 30, 2020 | 42.36M |
March 31, 2020 | 42.60M |
December 31, 2019 | 44.06M |
September 30, 2019 | 33.60M |
June 30, 2019 | 34.06M |
March 31, 2019 | 24.68M |
December 31, 2018 | 18.73M |
September 30, 2018 | 32.08M |
June 30, 2018 | 13.84M |
March 31, 2018 | 12.15M |
December 31, 2017 | 12.00M |
Date | Value |
---|---|
September 30, 2017 | -0.362M |
June 30, 2017 | -0.866M |
March 31, 2017 | 7.29M |
December 31, 2016 | 3.196M |
September 30, 2016 | 4.884M |
June 30, 2016 | 14.40M |
March 31, 2016 | 11.76M |
December 31, 2015 | 12.42M |
September 30, 2015 | 8.761M |
June 30, 2015 | 7.079M |
March 31, 2015 | 1.82M |
December 31, 2014 | 12.80M |
September 30, 2014 | 19.79M |
June 30, 2014 | 19.11M |
March 31, 2014 | 25.42M |
December 31, 2013 | 21.30M |
September 30, 2013 | 21.98M |
June 30, 2013 | 20.24M |
March 31, 2013 | 13.87M |
December 31, 2012 | 12.18M |
September 30, 2012 | 5.363M |
June 30, 2012 | 0.3242M |
March 31, 2012 | -0.0867M |
September 30, 2011 | -0.713M |
June 30, 2011 | 0.3538M |
Free Cash Flow Range, Past 5 Years
14.50M
Minimum
Sep 2022
97.48M
Maximum
Sep 2023
44.08M
Average
42.36M
Median
Jun 2020
Free Cash Flow Benchmarks
Perspective Therapeutics Inc | -37.98M |
Retractable Technologies Inc | 1.914M |
Xtant Medical Holdings Inc | -10.97M |
Asensus Surgical Inc | -64.19M |
Catheter Precision Inc | -20.70M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | 29.06M |
Cash from Investing (Quarterly) | -169.90M |
Cash from Financing (Quarterly) | 268.13M |
Free Cash Flow Per Share (Quarterly) | 0.3216 |
Free Cash Flow to Equity (Quarterly) | -275.69M |
Free Cash Flow to Firm (Quarterly) | 40.77M |
Free Cash Flow Yield | 0.80% |